Kamada Ltd. (NASDAQ:KMDA) Q2 2022 Earnings Conference Call August 17, 2022 8:30 AM ET

Company Representatives

Amir London - Chief Executive Officer

Chaime Orlev - Chief Financial Officer

Bob Yedid - LifeSci Advisors

Conference Call Participants

Anthony Petrone - Mizuho Group

Operator

Greetings, and welcome to the Kamada Ltd., Second Quarter 2022 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Bob Yedid. Thank you. You may begin.

Bob Yedid

Thank you all for participating in today’s call. This is Bob Yedid with LifeSci Advisors. Joining me from Kamada are Amir London, Chief Executive Officer; and Chaime Orlev, Chief Financial Officer.

Earlier today Kamada announced its financial results for the three and six months ended June 30, 2022. If you have not received this news release, please go to the Investors page of the company's website at www.kamada.com.

Before we begin, I'd like to caution that comments made during this conference call by management will contain forward-looking statements that involve risks and uncertainties regarding the operations and future results of Kamada. I encourage you to review the company's filings with the Securities and Exchange Commission, including without limitation the company's Forms 20-F and 6-K, which identifies specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Furthermore, the content of this conference call contains time-sensitive information that is accurate only as of the date of the live broadcast, Wednesday, August 17, 2022. The company undertakes no obligation to revise or update any statements to reflect events or circumstances after the date of this call.

Before turning the call over to management, analysts or investors can email questions for the question-and-answer session to my email address at the end of the press release, Bob Yedid – excuse me, bob@lifesciadvisors.com Also you can prompt and ask questions live as usual on any conference call at the end here and Melissa will give those instructions.

With that said, it's my pleasure to turn the call over to Amir London, CEO. Amir?

Amir London

Thank you, Bob. My thanks also to our investors and analysts who have interest in Kamada and for participating in today’s call. Let me start by emphasizing the six months into 2022 and based on our positive outlook for the rest of the year, we are highly encouraged by the performance of our business in 2022. I believe it is a testament to our ability to rapidly transition from our past dependency on GLASSIA sales to Takeda to a diversified fully integrated commercial company and a global leader in the plasma-derived specialty market.